Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 29, 2015European Heart Journal

Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAnders Bruun MathiasenUniversity of CopenhagenAQAbbas Ali QayyumUniversity of CopenhagenEJErik JørgensenUniversity of Copenhagen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mathiasen et al. (2015) studied this question.

synapsesocial.com/papers/697817fb78c42d0bce33a06bhttps://doi.org/10.1093/eurheartj/ehv136
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Stem cell therapy for end-stage heart failure: indispensable role for the cell?2009 · 21 citations
  2. 2Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.1987 · 2,379 citations
  3. 3Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation2010 · 710 citations